 BetterLife Pharma Inc announced that its wholly-owned subsidiary, Altum Pharmaceuticals Inc, and Pontificia Universidad Católica de Chile have obtained approval to conduct their planned randomized placebo-controlled trial IN2COVID on coronavirus COVID-19 patients. The trial, which was approved by Instituto de Salud Publica de Chile, is set to start in early August. 